BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35271738)

  • 1. Prevalence of oral manifestations in COVID-19: A systematic review.
    Sharma P; Malik S; Wadhwan V; Gotur Palakshappa S; Singh R
    Rev Med Virol; 2022 Nov; 32(6):e2345. PubMed ID: 35271738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Manifestations in Patients with COVID-19: A Living Systematic Review.
    Amorim Dos Santos J; Normando AGC; Carvalho da Silva RL; Acevedo AC; De Luca Canto G; Sugaya N; Santos-Silva AR; Guerra ENS
    J Dent Res; 2021 Feb; 100(2):141-154. PubMed ID: 32914677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
    Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
    Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis.
    Aragoneses J; Suárez A; Algar J; Rodríguez C; López-Valverde N; Aragoneses JM
    Front Med (Lausanne); 2021; 8():726753. PubMed ID: 34513886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.
    Orilisi G; Mascitti M; Togni L; Monterubbianesi R; Tosco V; Vitiello F; Santarelli A; Putignano A; Orsini G
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucosal lesions in patients with COVID-19: a systematic review.
    Bhujel N; Zaheer K; Singh RP
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1024-1030. PubMed ID: 34563354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.
    Gebretsadik HG
    PLoS One; 2022; 17(10):e0275817. PubMed ID: 36269692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.
    Erbaş GS; Botsali A; Erden N; Arı C; Taşkın B; Alper S; Vural S
    Int J Dermatol; 2022 Jan; 61(1):20-32. PubMed ID: 34549816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions.
    Favas TT; Dev P; Chaurasia RN; Chakravarty K; Mishra R; Joshi D; Mishra VN; Kumar A; Singh VK; Pandey M; Pathak A
    Neurol Sci; 2020 Dec; 41(12):3437-3470. PubMed ID: 33089477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological manifestations of COVID-19: a systematic review and detailed comprehension.
    Ousseiran ZH; Fares Y; Chamoun WT
    Int J Neurosci; 2023 Jul; 133(7):754-769. PubMed ID: 34433369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the prevalence of oral manifestations in COVID-19 patients: a systematic review.
    Gupta A; Shrivastav K; Agrawal A; Purohit A; Chanchlani R
    Osong Public Health Res Perspect; 2023 Oct; 14(5):388-417. PubMed ID: 37920896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study.
    Fernandes TJ; Ogrzewalska M; Martins EB; de Siqueira MAMT; Brasil P; Calvet GA
    BMC Oral Health; 2023 Sep; 23(1):696. PubMed ID: 37759210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral manifestations of COVID-19 and its management in pediatric patients: A systematic review and practical guideline.
    Nasiri K; Tehrani S; Mohammadikhah M; Banakar M; Alaeddini M; Etemad-Moghadam S; Fernandes GVO; Heboyan A; Imannezhad S; Abbasi F
    Clin Exp Dent Res; 2023 Oct; 9(5):922-934. PubMed ID: 37602892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
    Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with COVID-19 may present some oral manifestations.
    Sofi-Mahmudi A
    Evid Based Dent; 2021 Jan; 22(2):80-81. PubMed ID: 34172917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.
    Hawkings MJ; Vaselli NM; Charalampopoulos D; Brierley L; Elliot AJ; Buchan I; Hungerford D
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral manifestations in SARS-CoV-2 infection.
    Tuter G; Yerebakan M; Celik B; Kara G
    Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e330-e339. PubMed ID: 35717616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Oral Mucosal Lesions: a Systematic Review.
    Pergolini D; Graniero F; Magnifico L; Migliau G; Rocchetti F; Mohsen A; Tenore G; Romeo U; Palaia G
    Clin Ter; 2023; 174(6):550-563. PubMed ID: 38048120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.